» Articles » PMID: 29311662

Evidence for a Radiation-responsive 'p53 Gateway' Contributing Significantly to the Radioresistance of Lepidopteran Insect Cells

Overview
Journal Sci Rep
Specialty Science
Date 2018 Jan 10
PMID 29311662
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, we have demonstrated that microRNA-31 (miR-31) overexpression is inherent to radiation-induced cell death in the highly radioresistant Sf9 insect cells, and regulates pro-apoptotic Bax translocation to mitochondria. In the present study, we report that at sub-lethal radiation doses for Sf9 cells, miR-31 is significantly downregulated and is tightly regulated by an unusual mechanism involving p53. While ectopic overexpression of a well-conserved Sfp53 caused typical apoptosis, radiation-induced p53 accumulation observed selectively at sub-lethal doses failed to induce cell death. Further investigation of this paradoxical response revealed an intriguing phenomenon that sub-lethal radiation doses result in accumulation of a 'hyper-phosphorylated' Sfp53, which in turn binds to miR-31 genomic location and suppresses its expression to prevent cell death. Interestingly, priming cells with sub-lethal doses even prevented the apoptosis induced by lethal radiation or ectopic Sfp53 overexpression. On the other hand, silencing p53 increased radiation-induced cell death by inhibiting miR-31 downregulation. This study thus shows the existence of a unique radiation-responsive 'p53 gateway' preventing miR-31-mediated apoptosis in Sf9 cells. Since Sfp53 has a good functional homology with human p53, this study may have significant implications for effectively modulating the mammalian cell radioresistance.

Citing Articles

Impact of mutations on brain metastasis control in non-small cell lung cancer patients undergoing stereotactic radiosurgery.

Leng J, Su C, Carpenter D, Floyd W, Vaios E, Shenker R J Radiosurg SBRT. 2024; 9(2):91-99.

PMID: 39087065 PMC: 11288656.


On the Boundary of Exploratory Genomics and Translation in Sequential Glioblastoma.

Tompa M, Galik B, Urban P, Kajtar B, Kraboth Z, Gyenesei A Int J Mol Sci. 2024; 25(14).

PMID: 39062807 PMC: 11277311. DOI: 10.3390/ijms25147564.


Relationship between p53 status and the bioeffect of ionizing radiation.

Kong X, Yu D, Wang Z, Li S Oncol Lett. 2021; 22(3):661.

PMID: 34386083 PMC: 8299044. DOI: 10.3892/ol.2021.12922.


The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma.

Krayem M, Sabbah M, Najem A, Wouters A, Lardon F, Simon S Cancers (Basel). 2019; 11(8).

PMID: 31374895 PMC: 6721382. DOI: 10.3390/cancers11081093.

References
1.
Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H . Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene. 2012; 32(27):3286-95. PMC: 3705163. DOI: 10.1038/onc.2012.334. View

2.
Levine A, Finlay C, Hinds P . P53 is a tumor suppressor gene. Cell. 2004; 116(2 Suppl):S67-9, 1 p following S69. DOI: 10.1016/s0092-8674(04)00036-4. View

3.
Luo J, Su F, Chen D, SHILOH A, Gu W . Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature. 2000; 408(6810):377-81. DOI: 10.1038/35042612. View

4.
Kuerbitz S, Plunkett B, Walsh W, Kastan M . Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A. 1992; 89(16):7491-5. PMC: 49736. DOI: 10.1073/pnas.89.16.7491. View

5.
Blom N, Gammeltoft S, Brunak S . Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol. 1999; 294(5):1351-62. DOI: 10.1006/jmbi.1999.3310. View